Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Schrodinger ( (SDGR) ) just unveiled an update.
On March 8, 2026, Schrödinger, Inc. appointed Vice President and Corporate Controller Therese Abrams as its principal accounting officer, formalizing the role for a long-serving finance executive who has held a series of senior financial and revenue-focused positions at the company since 2013. Abrams, a certified public accountant with prior experience at Jive Software, EVRAZ North America and KPMG, entered into the company’s standard indemnification agreement, and her compensation arrangements were unchanged with this designation.
The leadership change follows the March 6, 2026 transition of Jenny Herman from her position as Chief Accounting Officer and principal accounting officer, with Herman remaining through April 10, 2026 to support an orderly handover. The move underscores continuity in Schrödinger’s finance function by elevating an internal candidate with deep institutional knowledge, which may help ensure stability in financial reporting and controls during the transition period.
The most recent analyst rating on (SDGR) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on Schrodinger stock, see the SDGR Stock Forecast page.
Spark’s Take on SDGR Stock
According to Spark, TipRanks’ AI Analyst, SDGR is a Neutral.
The score is held back primarily by inconsistent financial performance (ongoing losses despite improved 2025 cash flow) and a clearly bearish technical trend. Earnings-call guidance and strategic clarity (ACV growth, hosted transition, path to profitability with strong cash) partially offset these risks, while valuation remains constrained by negative earnings and no dividend support.
To see Spark’s full report on SDGR stock, click here.
More about Schrodinger
Schrödinger, Inc. is a technology-driven life sciences company that develops advanced computational software solutions for drug discovery and materials science, supporting pharmaceutical, biotechnology and industrial customers in designing and optimizing novel compounds. The company pairs its software with collaborative research programs to accelerate innovation across the biopharmaceutical and broader science-driven industries.
Average Trading Volume: 1,335,126
Technical Sentiment Signal: Sell
Current Market Cap: $939.8M
For detailed information about SDGR stock, go to TipRanks’ Stock Analysis page.